Albany, NY -- (SBWIRE) -- 02/06/2019 -- The prostate is a walnut-sized gland located between the bladder and the penis. The prostate secretes fluid that nourishes and protects sperms. A prostate biopsy is very important in the diagnosis and treatment of prostate cancer. Prostate biopsy is a procedure to remove samples of suspicious tissue from the prostate. During the procedure, a needle is inserted into the prostate to take tissues out in order to check for prostate cancer, and this is usually done through the rectum. Doctors prefer to perform surgery on patients diagnosed with prostate cancer. If the cancer has spread to nearby tissue, doctors recommend therapies such as radiation, chemotherapy, hormone therapy, etc. to prevent cancer.
View Report: https://www.transparencymarketresearch.com/prostate-biopsy-system-market.html
Increase in the geriatric male population globally, rise in the incidence rate of prostate cancer, and availability of advanced diagnostic systems are major factors driving the global prostate biopsy devices market. Moreover, advancements in molecular diagnosis for prostate cancer augment the global prostate biopsy system market. However, high cost of biopsy procedures and shortage of skilled professionals are major factors restraining the market.
The global prostate biopsy system market can be segmented based on product, end-user, and region. Based on product, the global prostate biopsy system market can be classified into 3D imaging systems, 2D imaging systems, and accessories. The 3D imaging system segment is projected to account for a significant share of the market in the near future, as 3D imaging systems offer a great degree of accuracy of image-guided intervention by providing optimal visualization of the prostate organ as well as full access. In terms of end-user, the prostate biopsy system market can be categorized into hospitals, diagnostic centers, and others. The hospitals segment is expected to constitute a considerable share of the market during the forecast period, because a significant number of prostate surgeries and tests are performed in hospitals due to the availability of all types of devices and reimbursement facilities.
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53943
In terms of region, the global prostate biopsy system market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global prostate biopsy system market during the forecast period. The market in the region is primarily driven by a high incidence rate of prostate cancer cases in the U.S.. According to American Cancer Society estimates, around 164,690 new cases of prostate cancer cases are likely to be registered in 2018. The scenario is almost the same in Europe due to a high incidence of death due to prostate cancer and rise in awareness about the disease in the region.
According to Eurostat data, in 2015, 75.3 thousand men died from prostate cancer in the European Union. Awareness among people about the disease is a major factor propelling the market in Europe. In Asia Pacific, a developing health care infrastructure and favorable reimbursement for prostate cancer treatment are some factors that drive the market. Factors such as lack of awareness about diseases and unavailability of advanced biopsy procedures and treatment in some countries such as Iraq, Lenabon etc., are expected to hamper the prostate biopsy system market in Middle East & Africa.
Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=53943
Major players operating in the global prostate biopsy system market include Koninklijke Philips N.V., Eigen, 3D Biopsy Inc., BIOBOT SURGICAL PTE LTD, Cook, Boston Scientific Corporation, STERIS LAB S.r.l, and KOELIS.
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com